- Release Date: 14/06/22 16:09
- Summary: 31 March 2022 Preliminary Final Statement (Price Sensitive)
- Price Sensitive: Yes
- Download Document 323.66KB
- Forums
- NSX - By Stock
- Ann:31 March 2022 Preliminary Final Statement (Price Sensitive)
Ann:31 March 2022 Preliminary Final Statement (Price Sensitive)
Featured News
Featured News
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online